The store will not work correctly when cookies are disabled.
9-(4-Aminobutyl)-6-(benzyloxy)-9H-purin-2-amine
ID: ALA5207999
PubChem CID: 168296835
Max Phase: Preclinical
Molecular Formula: C16H20N6O
Molecular Weight: 312.38
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: NCCCCn1cnc2c(OCc3ccccc3)nc(N)nc21
Standard InChI: InChI=1S/C16H20N6O/c17-8-4-5-9-22-11-19-13-14(22)20-16(18)21-15(13)23-10-12-6-2-1-3-7-12/h1-3,6-7,11H,4-5,8-10,17H2,(H2,18,20,21)
Standard InChI Key: UURWATJCKKWXKH-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
-0.2023 -0.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3813 0.1372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1767 -0.0758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3904 -0.8736 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.8092 -1.4603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0122 -1.2467 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9476 -0.0535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8176 0.7414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0023 0.8649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7607 0.5081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5585 0.2943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1427 0.8784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9290 1.6765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5119 2.2582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3100 2.0443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5243 1.2509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9439 0.6637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6629 -0.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3783 -0.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0936 -0.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8090 -0.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5243 -0.4664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0230 -2.2582 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
1 7 1 0
7 8 1 0
9 8 2 0
2 9 1 0
3 10 1 0
10 11 1 0
11 12 1 0
13 12 2 0
14 13 1 0
15 14 2 0
16 15 1 0
17 16 2 0
12 17 1 0
7 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
5 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 312.38 | Molecular Weight (Monoisotopic): 312.1699 | AlogP: 1.73 | #Rotatable Bonds: 7 |
Polar Surface Area: 104.87 | Molecular Species: BASE | HBA: 7 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.20 | CX LogP: 1.72 | CX LogD: -0.88 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.64 | Np Likeness Score: -0.83 |
References
1. Franco Pinto J, Fillion A, Duchambon P, Bombard S, Granzhan A.. (2022) Acridine-O6-benzylguanine hybrids: Synthesis, DNA binding, MGMT inhibition and antiproliferative activity., 227 [PMID:34731767] [10.1016/j.ejmech.2021.113909] |